Synonyms: Adempas® | BAY 63-2521
riociguat is an approved drug (FDA (2013), EMA (2014))
Compound class:
Synthetic organic
Comment: Riociguat is the first-in-class stimulator of soluble guanylate cyclase (sGC) class of drugs.
|
|
Classification | |
Compound class | Synthetic organic |
Approved drug? | Yes (FDA (2013), EMA (2014)) |
IUPAC Name |
methyl N-(4,6-diamino-2-{1-[(2-fluorophenyl)methyl]-1H-pyrazolo[3,4-b]pyridin-3-yl}pyrimidin-5-yl)-N-methylcarbamate |
International Nonproprietary Names | |
INN number | INN |
8857 | riociguat |
Synonyms |
Adempas® | BAY 63-2521 |
Database Links | |
CAS Registry No. | 625115-55-1 |
ChEBI | CHEBI:76018 |
ChEMBL Ligand | CHEMBL2107834 |
DrugCentral Ligand | 4807 |
GtoPdb PubChem SID | 178101941 |
PubChem CID | 11304743 |
RCSB PDB Ligand | GZO |
Search Google for chemical match using the InChIKey | WXXSNCNJFUAIDG-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | WXXSNCNJFUAIDG |
Search PubMed clinical trials | riociguat |
Search PubMed titles | riociguat |
Search PubMed titles/abstracts | riociguat |
UniChem Compound Search for chemical match using the InChIKey | WXXSNCNJFUAIDG-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | WXXSNCNJFUAIDG-UHFFFAOYSA-N |
Wikipedia | Riociguat |